Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures

[1]  U. Reimer,et al.  Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors , 2020, medRxiv.

[2]  Jason A. Tetro,et al.  Is COVID-19 receiving ADE from other coronaviruses? , 2020, Microbes and Infection.

[3]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[4]  N. Hacohen,et al.  A large peptidome dataset improves HLA class I epitope prediction across most of the human population , 2019, Nature Biotechnology.

[5]  Russ B. Altman,et al.  Predicting HLA class II antigen presentation through integrated deep learning , 2019, Nature Biotechnology.

[6]  George Coukos,et al.  Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes , 2019, Nature Biotechnology.

[7]  S. Elledge,et al.  T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes , 2019, Cell.

[8]  S. S. Sohrab,et al.  A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model , 2019, The Journal of infectious diseases.

[9]  A. Crowley,et al.  Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function , 2019, Front. Immunol..

[10]  J. Juraszek,et al.  Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS , 2019, Scientific Reports.

[11]  Chuan Qin,et al.  Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. , 2019, JCI insight.

[12]  K. Burke,et al.  Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs , 2019, Science Translational Medicine.

[13]  Jaemoon Yang,et al.  Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer , 2019, Experimental & Molecular Medicine.

[14]  D. Burton,et al.  Commonality despite exceptional diversity in the baseline human antibody repertoire , 2018, Nature.

[15]  Weiping Jia,et al.  High-throughput determination of the antigen specificities of T cell receptors in single cells , 2018, Nature Biotechnology.

[16]  J. Crowe,et al.  Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. , 2018, Cell reports.

[17]  M. Halloran,et al.  Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.

[18]  P. Palese,et al.  Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization , 2017, Proceedings of the National Academy of Sciences.

[19]  Barney S. Graham,et al.  Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.

[20]  J. Utikal,et al.  Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.

[21]  P. Bradley,et al.  Quantifiable predictive features define epitope-specific T cell receptor repertoires , 2017, Nature.

[22]  Alessandro Sette,et al.  Identifying specificity groups in the T cell receptor repertoire , 2017, Nature.

[23]  Devin P. Sullivan,et al.  A subcellular map of the human proteome , 2017, Science.

[24]  Bjoern Peters,et al.  BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes , 2017, Nucleic Acids Res..

[25]  A. García-Sastre,et al.  Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity , 2017, Science.

[26]  Roland L. Dunbrack,et al.  The Rosetta all-atom energy function for macromolecular modeling and design , 2017, bioRxiv.

[27]  J. Ernst,et al.  Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice* , 2017, The Journal of Biological Chemistry.

[28]  John West,et al.  Proceedings of the International Conference for High Performance Computing, Networking, Storage and Analysis , 2016, SC.

[29]  Baoshan Zhang,et al.  Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination , 2016, Nature Medicine.

[30]  David Baker,et al.  Accurate de novo design of hyperstable constrained peptides , 2016, Nature.

[31]  Brian D. Weitzner,et al.  Modeling and docking of antibody structures with Rosetta , 2017, Nature Protocols.

[32]  Krishna Shankara Narayanan,et al.  Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus , 2016, Human vaccines & immunotherapeutics.

[33]  Jing Xie,et al.  Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates , 2016, ACS infectious diseases.

[34]  R. Bruzzone,et al.  Fc receptors in antibody‐dependent enhancement of viral infections , 2015, Immunological reviews.

[35]  Hongying Duan,et al.  Reverse Engineering of Vaccine Antigens Using High Throughput Sequencing-enhanced mRNA Display , 2015, EBioMedicine.

[36]  Fu-Tong Liu,et al.  Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins , 2014, Biochemical and Biophysical Research Communications.

[37]  J. Peiris,et al.  Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus , 2014, Virology Journal.

[38]  David Baker,et al.  Proof of principle for epitope-focused vaccine design , 2014, Nature.

[39]  R. Couch,et al.  Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus , 2012, PloS one.

[40]  J. Ravetch,et al.  Mouse model recapitulating human Fcγ receptor structural and functional diversity , 2012, Proceedings of the National Academy of Sciences.

[41]  C. Liu,et al.  “On silico” peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions , 2011, Nature Medicine.

[42]  N. Laird,et al.  Identifying causal rare variants of disease through family-based analysis of Genetics Analysis Workshop 17 data set , 2011, BMC proceedings.

[43]  A. Rothman.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms , 2011, Nature Reviews Immunology.

[44]  J. Peiris,et al.  Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway , 2011, Journal of Virology.

[45]  Uri Laserson,et al.  Autoantigen discovery with a synthetic human peptidome. , 2011, Nature biotechnology.

[46]  Jianjun Chen,et al.  Induction of Specific Immune Responses by Severe Acute Respiratory Syndrome Coronavirus Spike DNA Vaccine with or without Interleukin-2 Immunization Using Different Vaccination Routes in Mice , 2007, Clinical and Vaccine Immunology.

[47]  R. Johnston,et al.  Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants , 2006, PLoS medicine.

[48]  M. Peiris,et al.  Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro , 2006, Vaccine.

[49]  Bo Zhang,et al.  Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.

[50]  Y. Guan,et al.  Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis , 2005, Journal of Virology.

[51]  Kwanyee Leung,et al.  Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Proulx,et al.  Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets , 2004, Journal of Virology.

[53]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[54]  G. Ruthel,et al.  Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. , 2003, The Journal of infectious diseases.

[55]  Lanjuan Li,et al.  SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients , 2003, Journal of Clinical Virology.

[56]  Yun-Chi Chen,et al.  Activation of Terminally Differentiated Human Monocytes/Macrophages by Dengue Virus: Productive Infection, Hierarchical Production of Innate Cytokines and Chemokines, and the Synergistic Effect of Lipopolysaccharide , 2002, Journal of Virology.

[57]  Patricia W. Finn,et al.  Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life , 2002, The Journal of experimental medicine.

[58]  J. Mandell,et al.  Epitope mapping of a monoclonal antibody against human thrombin by H/D‐exchange mass spectrometry reveals selection of a diverse sequence in a highly conserved protein , 2002, Protein science : a publication of the Protein Society.

[59]  P. Parren,et al.  Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1 , 2001, Journal of Virology.

[60]  M. Klein,et al.  Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[61]  H. Vennema,et al.  Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization , 1990, Journal of virology.

[62]  S L Morrison,et al.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. , 1989, Journal of immunology.

[63]  Petersen Nc,et al.  Immunologic phenomena in the effusive form of feline infectious peritonitis. , 1980 .